368 related articles for article (PubMed ID: 29950437)
21. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.
Masek M; Vaneckova M; Krasensky J; Danes J; Havrdova E; Hrebikova T; Seidl Z
Neuro Endocrinol Lett; 2008 Aug; 29(4):461-6. PubMed ID: 18766142
[TBL] [Abstract][Full Text] [Related]
22. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
23. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
24. Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.
Liu Y; Duan Y; Huang J; Ren Z; Liu Z; Dong H; Weiler F; Hahn HK; Shi FD; Butzkueven H; Barkhof F; Li K
Eur Radiol; 2018 Jan; 28(1):96-103. PubMed ID: 28667482
[TBL] [Abstract][Full Text] [Related]
25. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
[TBL] [Abstract][Full Text] [Related]
26. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
[TBL] [Abstract][Full Text] [Related]
27. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
Traboulsee A; Dehmeshki J; Peters KR; Griffin CM; Brex PA; Silver N; Ciccarrelli O; Chard DT; Barker GJ; Thompson AJ; Miller DH
Mult Scler; 2003 Dec; 9(6):566-73. PubMed ID: 14664468
[TBL] [Abstract][Full Text] [Related]
28. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
[TBL] [Abstract][Full Text] [Related]
29. Cervical cord lesion load is associated with disability independently from atrophy in MS.
Kearney H; Altmann DR; Samson RS; Yiannakas MC; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
Neurology; 2015 Jan; 84(4):367-73. PubMed ID: 25540312
[TBL] [Abstract][Full Text] [Related]
30. Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
Haider L; Prados F; Chung K; Goodkin O; Kanber B; Sudre C; Yiannakas M; Samson RS; Mangesius S; Thompson AJ; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Chard DT; Barkhof F
Brain; 2021 Jun; 144(5):1384-1395. PubMed ID: 33880511
[TBL] [Abstract][Full Text] [Related]
31. Functional Disability and Brain MRI Volumetry Results among Multiple Sclerosis Patients during 5-Year Follow-Up.
Strautmane S; Balodis A; Teivane A; Grabovska D; Naudins E; Urbanovics D; Fisermans E; Mednieks J; Flintere-Flinte A; Priede Z; Millers A; Zolovs M
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374286
[No Abstract] [Full Text] [Related]
32. Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
Bischof A; Papinutto N; Keshavan A; Rajesh A; Kirkish G; Zhang X; Mallott JM; Asteggiano C; Sacco S; Gundel TJ; Zhao C; Stern WA; Caverzasi E; Zhou Y; Gomez R; Ragan NR; Santaniello A; Zhu AH; Juwono J; Bevan CJ; Bove RM; Crabtree E; Gelfand JM; Goodin DS; Graves JS; Green AJ; Oksenberg JR; Waubant E; Wilson MR; Zamvil SS; ; Cree BAC; Hauser SL; Henry RG
Ann Neurol; 2022 Feb; 91(2):268-281. PubMed ID: 34878197
[TBL] [Abstract][Full Text] [Related]
33. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.
Tavazzi E; Bergsland N; Kuhle J; Jakimovski D; Ramanathan M; Maceski AM; Tomic D; Hagemeier J; Kropshofer H; Leppert D; Dwyer MG; Weinstock-Guttman B; Benedict RHB; Zivadinov R
J Neurol; 2020 Mar; 267(3):802-811. PubMed ID: 31768628
[TBL] [Abstract][Full Text] [Related]
34. Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability.
Valsasina P; Aboulwafa M; Preziosa P; Messina R; Falini A; Comi G; Filippi M; Rocca MA
Radiology; 2018 Jul; 288(1):234-244. PubMed ID: 29664341
[TBL] [Abstract][Full Text] [Related]
35. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
Mirmosayyeb O; Brand S; Barzegar M; Afshari-Safavi A; Nehzat N; Shaygannejad V; Sadeghi Bahmani D
J Clin Med; 2020 May; 9(5):. PubMed ID: 32370288
[TBL] [Abstract][Full Text] [Related]
36. Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: relation to brain findings and clinical disability.
Daams M; Weiler F; Steenwijk MD; Hahn HK; Geurts JJ; Vrenken H; van Schijndel RA; Balk LJ; Tewarie PK; Tillema JM; Killestein J; Uitdehaag BM; Barkhof F
Mult Scler; 2014 Dec; 20(14):1860-5. PubMed ID: 24812042
[TBL] [Abstract][Full Text] [Related]
37. Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes.
Bernitsas E; Bao F; Seraji-Bozorgzad N; Chorostecki J; Santiago C; Tselis A; Caon C; Zak I; Millis S; Khan O
Mult Scler Relat Disord; 2015 Jan; 4(1):47-51. PubMed ID: 25787052
[TBL] [Abstract][Full Text] [Related]
38. The role of endogenous antiradical protective system in multiple sclerosis.
Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
[TBL] [Abstract][Full Text] [Related]
39. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
Ozakbas S; Ormeci B; Idiman E
J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
[TBL] [Abstract][Full Text] [Related]
40. Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study.
Stankiewicz JM; Neema M; Alsop DC; Healy BC; Arora A; Buckle GJ; Chitnis T; Guttmann CR; Hackney D; Bakshi R
J Neurol Sci; 2009 Apr; 279(1-2):99-105. PubMed ID: 19178916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
